The recommended pause in administration of Janssen Biotech Inc.’s coronavirus vaccine likely will continue at least several more days while the US Centers for Disease Control and Prevention gathers additional data on cases of rare blood clots.
CDC Advisory Committee on Immunization Practices (ACIP) members want the extra time to better inform their decision on whether to...







